Search Results - "Candels, Lena Susanna"
-
1
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
Published in Nature communications (08-07-2022)“…Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, and therapeutic options for advanced HCC are limited. Here, we observe…”
Get full text
Journal Article -
2
Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis
Published in International journal of molecular sciences (14-01-2019)“…Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in western countries, with a continuously rising incidence. Gut-liver communication…”
Get full text
Journal Article -
3
PLA2G7: a new player in shaping energy metabolism and lifespan
Published in Signal transduction and targeted therapy (17-06-2022)Get full text
Journal Article -
4
-
5
-
6
WED-521-YI Tissue-specific roles of Farnesoid X Receptor in gut-liver axis and influence on progressive cholestatic liver injury
Published in Journal of hepatology (01-06-2024)Get full text
Journal Article -
7
SAT-292 - Intermittent fasting improves tumor-directed drug delivery by caveolar-mediated endocytosis
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
8
PNPLA3 I148M substitution excerbate NAFLD under a long-term high fat diet
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
9
WED-470 - PNPLA3 I148M substitution excerbate NAFLD under a long-term high fat diet
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
10
Intermittent fasting improves tumor-directed drug delivery by caveolar-mediated endocytosis
Published in Journal of hepatology (01-06-2023)Get full text
Journal Article -
11
Intermittent Fasting Primes the Tumor Microenvironment and Improves Nanomedicine Delivery in Hepatocellular Carcinoma
Published in Small (Weinheim an der Bergstrasse, Germany) (01-10-2023)“…Fasting has many health benefits, including reduced chemotherapy toxicity and improved efficacy. It is unclear how fasting affects the tumor microenvironment…”
Get full text
Journal Article -
12
Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
Published in Cellular and molecular gastroenterology and hepatology (01-01-2021)“…Acute liver failure (ALF) represents an unmet medical need in Western countries. Although the link between intestinal dysbiosis and chronic liver disease is…”
Get full text
Journal Article -
13
Gut microbiota drives hepatocarcinogenesis by promoting TLR4-dependent expansion of monocytic myeloid-derived suppressor cells
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article -
14
GS04 - Gut microbiota drives hepatocarcinogenesis by promoting TLR4-dependent expansion of monocytic myeloid-derived suppressor cells
Published in Journal of hepatology (01-08-2020)Get full text
Journal Article -
15
Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling
Published in Nature metabolism (01-09-2021)“…Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown aetiology for which there are no approved therapeutic options. Patients…”
Get full text
Journal Article -
16
Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver InjurySummary
Published in Cellular and molecular gastroenterology and hepatology (01-01-2021)“…Background & Aims: Acute liver failure (ALF) represents an unmet medical need in Western countries. Although the link between intestinal dysbiosis and chronic…”
Get full text
Journal Article